T0	Interventions 22 47	gonadotropin combinations
T1	Interventions 140 182	human recombinant FSH/human recombinant LH
T2	Interventions 202 247	highly purified human menopausal gonadotropin
T3	Interventions 560 624	human recombinant FSH (r-hFSH) plus human recombinant LH (r-hLH)
T4	Interventions 645 715	highly purified human menopausal gonadotropin (hMG-HP) urinary extract
T5	Interventions 912 930	150 IU hMG-HP (150
T6	Interventions 988 1010	150IU r-hFSH/75IU rhLH
T7	Interventions 1125 1148	hMG-HP or r-hFSH/r-hLH.
T8	Interventions 1501 1520	70% of r-hFSH/r-hLH
T9	Interventions 1566 1572	88% in
T10	Interventions 1605 1623	PR in r-hFSH/r-hLH
T11	Interventions 1652 1667	23.3% in hMG-HP
T12	Interventions 1781 1792	superiority
T13	Interventions 1799 1810	compared to
T14	Interventions 1818 1828	supporting